What is Propanc Biopharma, Inc. Common Stock's Market Cap?

Propanc Biopharma, Inc. Common Stock's Market Cap is $16.3M, based on as-reported figures from SEC (XBRL) filings.

What is Propanc Biopharma, Inc. Common Stock's Enterprise Value?

Propanc Biopharma, Inc. Common Stock's Enterprise Value is $16.8M, based on as-reported figures from SEC (XBRL) filings.

What is Propanc Biopharma, Inc. Common Stock's EV / EBITDA?

Propanc Biopharma, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Propanc Biopharma, Inc. Common Stock's Net Income (TTM)?

Propanc Biopharma, Inc. Common Stock's Net Income (TTM) is -$67.0M, based on as-reported figures from SEC (XBRL) filings.

What is Propanc Biopharma, Inc. Common Stock's EBITDA?

Propanc Biopharma, Inc. Common Stock's EBITDA is -$65.1M, based on as-reported figures from SEC (XBRL) filings.

What is Propanc Biopharma, Inc. Common Stock's Diluted EPS (TTM)?

Propanc Biopharma, Inc. Common Stock's Diluted EPS (TTM) is -4.22, based on as-reported figures from SEC (XBRL) filings.

What is Propanc Biopharma, Inc. Common Stock's Net Debt?

Propanc Biopharma, Inc. Common Stock's Net Debt is -$506.2K, based on as-reported figures from SEC (XBRL) filings.

Propanc Biopharma, Inc. Common Stock (PPCB) Financial Statements

Propanc Biopharma, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG002086411

XNAS · usd

1.03▲ 0.02 (1.98%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close1.01

Day's Range0.99 – 1.04

52-Week Range0.06 – 6.79

Volume172.3K

Avg Volume3.5M

Share Statistics

Shares Outstanding

Employees2

ExchangeXNAS

Listed2012-06-15

Share count as of February 16, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Propanc Biopharma, Inc. Common Stock (PPCB)

What is Propanc Biopharma, Inc. Common Stock's Market Cap?: Propanc Biopharma, Inc. Common Stock's Market Cap is $16.3M, based on as-reported figures from SEC (XBRL) filings.
What is Propanc Biopharma, Inc. Common Stock's Enterprise Value?: Propanc Biopharma, Inc. Common Stock's Enterprise Value is $16.8M, based on as-reported figures from SEC (XBRL) filings.
What is Propanc Biopharma, Inc. Common Stock's EV / EBITDA?: Propanc Biopharma, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Propanc Biopharma, Inc. Common Stock's Net Income (TTM)?: Propanc Biopharma, Inc. Common Stock's Net Income (TTM) is -$67.0M, based on as-reported figures from SEC (XBRL) filings.
What is Propanc Biopharma, Inc. Common Stock's EBITDA?: Propanc Biopharma, Inc. Common Stock's EBITDA is -$65.1M, based on as-reported figures from SEC (XBRL) filings.
What is Propanc Biopharma, Inc. Common Stock's Diluted EPS (TTM)?: Propanc Biopharma, Inc. Common Stock's Diluted EPS (TTM) is -4.22, based on as-reported figures from SEC (XBRL) filings.
What is Propanc Biopharma, Inc. Common Stock's Net Debt?: Propanc Biopharma, Inc. Common Stock's Net Debt is -$506.2K, based on as-reported figures from SEC (XBRL) filings.